WallStreetZenWallStreetZen

NASDAQ: TSHA
Taysha Gene Therapies Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Taysha Gene Therapies revenue was $9.77M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $5.5M, up Infinity% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TSHA annual revenue was $9.8M, with 17.3% growth year-over-year.

TSHA past revenue growth

How has TSHA's revenue growth performed historically?

Company
17.28%
Industry
453.65%
Market
89.96%
TSHA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TSHA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TSHA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TSHA revenue history

Current Revenue
$9.8M
Current Earnings
-$109.0M
Current Profit Margin
-1,115.3%

Be the first to know when TSHA announces revenue.

TSHA Revenue History By Year

TSHA Yearly RevenueTSHA RevenueTSHA ChangeTSHA Revenue Growth
2025-12-31$9.77M$1.44M+17.28%
2024-12-31$8.33M-$7.12M-46.07%
2023-12-31$15.45M$12.95M+517.55%
2022-12-31$2.50MN/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A

1 of 1

Taysha Gene Therapies Revenue FAQ

What was TSHA's revenue last quarter?

On Invalid Date, Taysha Gene Therapies (NASDAQ: TSHA) reported Q4 2025 revenue of $5.49 million up 171.27% year over year. In the same quarter last year, Taysha Gene Therapies's revenue was $2.02 million.

What was Taysha Gene Therapies's revenue in 2025?

Taysha Gene Therapies's annual revenue for the twelve months ending Dec 31, 2025 was $9.77 million, a 17.28% increase year over year.

How much does Taysha Gene Therapies make in a day?

Based on Taysha Gene Therapies annual revenue for the past five years, TSHA makes an average of $19,758.36 per day.

What was Taysha Gene Therapies's annual revenue growth in the past year?

As of Q1 2026, Taysha Gene Therapies's revenue has grown 17.28% year over year. This is 436.37 percentage points lower than the US Biotechnology industry revenue growth rate of 453.65%. Taysha Gene Therapies's revenue in the past year totaled $9.77 million.

How much does Taysha Gene Therapies make in a year?

Taysha Gene Therapies's revenue by year for the past five years is:
  • Taysha Gene Therapies's revenue for the twelve months ending Dec 31, 2025 was $9.77 million, a 17.28% increase year over year.
  • Taysha Gene Therapies's annual revenue for Dec 31, 2024 was $8.33 million, a 46.07% decrease from 2023.
  • Taysha Gene Therapies's annual revenue for 2023 was $15.45 million, a 517.55% increase from 2022.
  • Taysha Gene Therapies's annual revenue for 2022 was $2.50 million, a Infinity% increase from 2021.
  • Taysha Gene Therapies's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.